CSF2 and cancer: Our analyses using both the standard CD14 and the CD66 containing lineage cocktails to enumerate DCs in normal donors and cancer patients prior to receiving cytotoxic chemotherapy and GM-CSF reveal a slightly higher DC percentage of circulating DCs in nucleated leukocytes than has generally been reported, particularly in Gates A and B. Our data is comparable to reports evaluating DC populations in cord blood.